News | November 01, 2010

Importance of Refurbished Equipment to be Highlighted at ASTRO

November 1, 2010 – As the world’s population continues to age, refurbished radiation therapy equipment will become more important. Radiology Oncology Systems (R.O.S.) will demonstrate the importance of refurbished equipment at the American Society of Therapeutic Radiology (ASTRO) conference in San Diego, Calif.

Four groups of customers are now considering refurbished equipment more often. Hospitals often need secondary or back-up equipment to treat growing patient volumes, both at their main hospitals and at satellite clinics. Independent clinics may seek to establish lower-cost facilities, such as those with low patient volumes or those in remote areas. Also, radiation therapy clinic networks may relocate equipment frequently and require a mix of new and refurbished equipment. Finally, in many cases, international customers require refurbished solutions to make opening their centers feasible.

“Years ago, only smaller, independent clinics sought refurbished radiation therapy equipment, namely linear accelerators, CT simulators and brachytherapy units,” said Michael Teague, director of U.S. sales. “But today, we see a lot more demand from hospitals and networks. Having a refurbished machine doesn’t mean you have an inferior product, since virtually every machine in use today is considered ‘used’ after the first patient is treated.”

For more information: www.oncologysystems.com

Related Content

Bladder Abdomen Pelvis image with DLCExpert
News | Artificial Intelligence | November 07, 2019
November 7, 2019 — Mirada Medical, a global leader in...
Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...
MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment
News | Treatment Planning | October 18, 2019
The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an...
Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Feature | Prostate Cancer | October 16, 2019 | By Jeff Zagoudis
Radiation therapy is an important tool in the clinician’s armamentarium for treatment of localized, early-stage prost
Videos | Radiation Oncology | October 11, 2019
Lorraine Drapek, DNP, nurse practitioner, radiation oncology, GI service,...
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...